• Khazaeli, M., LoBuglio, A., Falcey, J., Paulter, V., Fetzer, M., & Waksal, H. (2000). Low immunogenicity of a chimeric monoclonal antibody (MOAB), IMC-C225, used to treat epidermal growth factor receptor-positive tumors. Proc Am Soc Clin Oncol , 808.• Kinzler, K., & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. , 87, 159. • Kinzler, K., & Vogelstein, B. (2002). The Genetic Basis of Human Cancer (2nd Edition ed.). New York: McGraw-Hill.